Communiqués

21/05 Report from the Annual General Meeting 2026 of i-tech AB (publ) AQ
20/05 Change to the Board nomination proposal ahead of I‑Tech AB’s Annual General Meeting AQ
07/05 I-Tech AB (publ) (ticker: ITECH) publish the interim report for Q1 2026 AQ
05/05 EU extends approval for Selektope® until 31 December 2026 AQ
17/04 I-Tech’s Annual Report 2025 is published AQ
18/03 I Tech announces change of Certified Adviser AQ
09/02 I-Tech (Q4 Review): Short-term volatility persists, long-term case intact AQ
05/02 Time for live year-end report presentation AQ
05/02 I-Tech AB (publ) (ticker: ITECH) publish the year-end report for 2025 AQ
17/12 Raouf Kattan resigns as a board member of I-Tech AB (publ) AQ
27/11 I-Tech strongly rejects the European Commission’s proposed non-renewal of Medetomidine under the EU Biocidal Products Regulation (BPR) AQ
24/11 I-Tech and Havey sign MoU to collaborate on the development of next-generation antifouling materials AQ
18/11 I-Tech's Nomination Committee appointed AQ
21/10/25 I-Tech (Q3 Review) - Forecasts Trimmed, Long-Term View Unchanged AQ
17/10/25 I-Tech AB (publ) (ticker: ITECH) publish the interim report for the third quarter 2025 AQ
25/08/25 I-Tech - Q2 Review – Temporary Slowdown AQ
22/08/25 I-Tech AB (publ) (ticker: ITECH) publish the interim report for the second quarter 2025 AQ
13/06/25 I-Tech announces outcome of warrant exercise AQ
23/05/25 I-Tech announces a one year extension of the current EU Approval for Selektope (Medetomidine) AQ
15/05/25 Report from the Annual General Meeting 2025 of I-tech AB (publ) AQ
12/05/25 I-Tech Q1 Review - Upward Adjustments AQ
11/04/25 I-Tech’s Annual Report 2024 is published AQ
10/02/25 I-Tech - Q4 Review – Full Sail AQ
06/02/25 I-Tech AB (publ) (ticker: ITECH) publish the Year-end report for 2024 AQ
30/01/25 I-Tech AB signs supply and license agreement with major Asian-based paint company AQ
Aucun résultat pour cette recherche